Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BASILIXIMAB Cause Respiratory failure? 200 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Respiratory failure have been filed in association with BASILIXIMAB (Simulect). This represents 2.9% of all adverse event reports for BASILIXIMAB.

200
Reports of Respiratory failure with BASILIXIMAB
2.9%
of all BASILIXIMAB reports
137
Deaths
124
Hospitalizations

How Dangerous Is Respiratory failure From BASILIXIMAB?

Of the 200 reports, 137 (68.5%) resulted in death, 124 (62.0%) required hospitalization, and 81 (40.5%) were considered life-threatening.

Is Respiratory failure Listed in the Official Label?

Yes, Respiratory failure is listed as a known adverse reaction in the official FDA drug label for BASILIXIMAB.

What Other Side Effects Does BASILIXIMAB Cause?

Cytomegalovirus infection (590) Drug ineffective (567) Off label use (567) Transplant rejection (554) Kidney transplant rejection (456) Product use in unapproved indication (428) Pyrexia (323) Diarrhoea (314) Multiple organ dysfunction syndrome (298) Polyomavirus-associated nephropathy (298)

What Other Drugs Cause Respiratory failure?

PREDNISONE (2,299) CYCLOPHOSPHAMIDE (2,096) RITUXIMAB (1,838) TACROLIMUS (1,758) METHOTREXATE (1,685) DEXAMETHASONE (1,603) MYCOPHENOLATE MOFETIL (1,469) METHYLPREDNISOLONE (1,442) PREDNISOLONE (1,346) VINCRISTINE (1,120)

Which BASILIXIMAB Alternatives Have Lower Respiratory failure Risk?

BASILIXIMAB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH BASILIXIMAB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED BASILIXIMAB vs BCG VACCINE BASILIXIMAB vs BEBTELOVIMAB BASILIXIMAB vs BECLOMETHASONE

Related Pages

BASILIXIMAB Full Profile All Respiratory failure Reports All Drugs Causing Respiratory failure BASILIXIMAB Demographics